In January 2025, China’s State Administration for Market Regulation (“SAMR”) introduced the Compliance Guidelines for Healthcare Companies to Prevent Commercial Bribery Risks (“Guidelines”), marking the first...more
China’s 2025 revision to the Anti-Unfair Competition Law (AUCL), effective 15 October 2025, marks a major regulatory shift aimed at strengthening market integrity and aligning with global enforcement trends. The law...more
On January 14, 2025, China issued the final version of its compliance guidelines for health care companies to prevent commercial bribery risks (“Guidelines”), which took effect immediately. The Guidelines are applicable to...more
With effect from March 1, 2024, China’s amended Criminal Law on bribery offences will come into force. Amidst China’s active anti-corruption movement, the amendments passed by the Standing Committee of the 14th National...more